Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey
  4. Indiana Health Center COVID-19 Survey Summary Report

Indiana Health Center COVID-19 Survey Summary Report

Latest data from June 17, 2022

Number of Health Center respondents = 13 (48% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 1,758
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 58.47%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 229
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 56.14%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 35.84% 32.75%
White, Hispanic/Latino Patients 14.85% 13.97%
Black/African American, Non-Hispanic/Latino Patients 21.50% 17.47%
Black/African American, Hispanic/Latino Patients 0.68% 0.44%
Asian Patients3 5.29% 1.75%
American Indian/Alaska Native Patients3 0.28% 1.75%
Native Hawaiian/Other Pacific Islander Patients3 0.68% 0.44%
Patients with More Than One Race3 1.99% 1.75%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.18% 4.37%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.97% 0.87%
Unreported/Refused to Report Race and Ethnicity 12.74% 24.45%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 417
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 84.77%
COVID-19 Immunization Series Completed 278
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 85.39%
COVID-19 Immunization Series Additional 687
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 65.40%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 14.39% 14.03% 33.19%
White, Hispanic/Latino Patients 15.11% 17.99% 13.83%
Black/African American, Non-Hispanic/Latino Patients 28.06% 26.26% 25.18%
Black/African American, Hispanic/Latino Patients 0.48% 1.80% 0.00%
Asian Patients3 5.76% 2.52% 2.62%
American Indian/Alaska Native Patients3 0.00% 0.36% 0.58%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 1.08% 1.16%
Patients with More Than One Race3 4.32% 2.88% 4.37%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 26.38% 29.14% 14.99%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.44% 0.72% 1.02%
Unreported/Refused to Report Race and Ethnicity 4.08% 3.24% 3.06%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 38.46%
1 to 24 Hours 15.38%
More Than 24 Hours 46.15%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 7.69%
Staffing to administer the vaccine 15.38%
Vaccine confidence 46.15%
Vaccine storage capacity 7.69%
Vaccine supply 0.00%
Other 7.69%
None 38.46%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 30.77%
Average Percent of Health Center Visits Conducted Virtually 8.08%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 23.08%
Number of Mobile Van Sites 2
Number of Pop-up Clinics 3
Number of School-Based Vaccination Sites 0
Number of Family Vaccination Clinics 13

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 7.69%
Refer patients to another organization that provides monoclonal antibody therapies 61.54%
None 30.77%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 7.69%
Patient awareness/education 0.00%
Staffing capacity 15.38%
Therapy administration/onsite logistics 7.69%
Other 7.69%
None 69.23%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 10
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 3,767

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 60.00%
Provided to General Public Who Came to the Health Center 60.00%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 20.00%
Provided at Other Community Events 40.00%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 0.00%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 0.00%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 0.00%
Provided to school-age children and/or their families directly or through partnerships with schools 10.00%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 0.00%
Other 30.00%

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 7
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 3,810

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 85.71%
Provided to General Public Who Came to the Health Center 71.43%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 14.29%
Provided at Other Community Events 42.86%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 0.00%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 14.29%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 14.29%
Provided to school-age children and/or their families directly or through partnerships with schools 14.29%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 0.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 3
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 33.33%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 53.33%
White, Hispanic/Latino Patients 16.67%
Black/African American, Non-Hispanic/Latino Patients 3.33%
Black/African American, Hispanic/Latino Patients 3.33%
Asian Patients3 3.33%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 3.33%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.33%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.67%
Unreported/Refused to Report Race and Ethnicity 6.67%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 0.00%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed: